Latest Innovation News

Forrestania Resources has inked a binding agreement with Polaris Engineering to construct a new carbon-in-leach plant at Lake Johnston, aiming for commissioning by November 2026 and a throughput of 3.2 million tonnes per annum.

Fatfish Group has revealed improper conduct by a former service provider that delayed its 2024 financial reporting, while outlining ongoing legal actions and a strategy to relist on the ASX within four months.

4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.

1414 Degrees has raised $2.69 million to accelerate its clean energy storage technologies, targeting the booming global data centre market and industrial energy users.

AdAlta’s subsidiary AdCella has completed its first Joint Development Committee meeting with Shanghai Cell Therapy Group, advancing the development of the CAR-T therapy BZDS1901 with potential timeline acceleration and reduced regulatory risks.

RLF AgTech has raised $4.5 million through an institutional placement to accelerate its commercial rollout and meet rising demand amid global fertiliser shortages.

Weebit Nano has successfully raised A$87 million through institutional and Israeli placements, positioning itself to fast-track its advanced ReRAM technology development. The capital raise includes a forthcoming share purchase plan for retail investors.

Temas Resources has formed a Scientific Advisory Board of hydrometallurgical leaders to accelerate the rollout of its innovative Regenerative Chloride Leaching technology, promising major cost and environmental benefits in critical minerals processing.

Titomic Limited has secured a significant $1.7 million purchase order from the Netherlands’ Royal NLR, reinforcing its foothold in European aerospace and defense additive manufacturing.

Radiopharm Theranostics has initiated dosing in its Phase 1 clinical trial of RAD 402, a novel radiolabelled antibody targeting KLK3 in advanced prostate cancer. Early data from the trial’s initial dose levels are expected in the second half of 2026.

Osteopore Limited has drawn down an additional $250,000 on the second tranche of its redeemable convertible notes, continuing its strategic funding partnership with Advance Opportunities Fund. This incremental funding supports the company’s ongoing business and future growth initiatives.

Weebit Nano has launched a significant A$80 million institutional placement, alongside additional funding initiatives, to accelerate its ReRAM technology leadership and broaden AI-related offerings.